Bioxytran, Inc. Announces the Reinitiation of Coverage of Its Stock by Avise Analytics
22 nov. 2022 08h00 HE
|
BIOXYTRAN, INC.
BOSTON, MASSACHUSETTS, Nov. 22, 2022 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT), a clinical stage biotechnology company developing novel therapies targeting the treatment of significant unmet...